Add this topic to your myFT Digest for news straight to your inbox
Share sale may return star fund manager to the ascendant
US activist investor snaps up shares in gene editing group from Neil Woodford
Tie-ups with big pharma are set to propel revenues to new heights
Several UK small-cap stocks stand out among their peers as ones to watch
Window for life science listings has not closed, despite the recent US sell-off
Investors including Invesco and Neil Woodford support share offering by anti-allergy specialist
International Edition